ABBV

AbbVie (ABBV)

About AbbVie (ABBV)

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Details

Daily high
$174.92
Daily low
$172.39
Price at open
$173.15
52 Week High
$207.32
52 Week Low
$151.29
Market cap
306.4B
Dividend yield
3.58%
Volume
5.5M
Avg. volume
6.3M
P/E ratio
60.46

AbbVie News

Details

Daily high
$174.92
Daily low
$172.39
Price at open
$173.15
52 Week High
$207.32
52 Week Low
$151.29
Market cap
306.4B
Dividend yield
3.58%
Volume
5.5M
Avg. volume
6.3M
P/E ratio
60.46